Induction Therapy of Tislelizumab Combined with Cisplatin and 5-Fluorouracil and Subsequent Conversion Surgery in Patients with Unresectable Advanced Esophageal Squamous Cell Carcinoma: A Phase 2, Single Center StudyTongpeng Xu, Yue Zhou, Kun Zhao et al.|Annals of Surgical Oncology|2024Cited by 8